Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
This grant opportunity supports research to validate tests used in cancer treatment, control, or prevention. It focuses on both analytical and clinical validation. The first phase (UH2) funds the analytical validation of tests on human samples, which must be completed in 2 years. The second phase (UH3) provides funding for up to 3 years to validate these tests clinically, using samples from cl…
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications to further optimize and validate molecular/cellular/imaging markers (referred to as "markers" or "biomarkers") and assays for cancer detection, diagnosis, prognosis, monitoring, and predic…
Funding Source
Eligibility
Foreign/Non-domestic entities: Non-domestic (non-U.S.) entities (foreign organizations) are NOT eligible to apply. Non-domestic (non-U.S.) components of U.S. organizations are NOT eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed within el…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers